NDC 80674-210

Sesquient

Fosphenytoin Sodium

Sesquient is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sedor Pharmaceuticals, Llc. The primary component is Fosphenytoin Sodium.

Product ID80674-210_8fa2abc6-e2d1-4647-a090-ca2f83481f5f
NDC80674-210
Product TypeHuman Prescription Drug
Proprietary NameSesquient
Generic NameFosphenytoin Sodium
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-06-01
Marketing CategoryNDA /
Application NumberNDA210864
Labeler NameSedor Pharmaceuticals, LLC
Substance NameFOSPHENYTOIN SODIUM
Active Ingredient Strength500 mg/10mL
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 80674-210-10

10 VIAL, SINGLE-USE in 1 CARTON (80674-210-10) > 10 mL in 1 VIAL, SINGLE-USE (80674-210-01)
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Sesquient" or generic name "Fosphenytoin Sodium"

NDCBrand NameGeneric Name
0069-5471CEREBYXFosphenytoin Sodium
0069-5474CEREBYXFosphenytoin Sodium
0069-6001CEREBYXFosphenytoin Sodium
63323-403FosphenytoinFOSPHENYTOIN SODIUM
0143-9782Fosphenytoin SodiumFosphenytoin Sodium
0143-9788Fosphenytoin SodiumFosphenytoin Sodium
0641-6136Fosphenytoin SodiumFosphenytoin Sodium
0641-6137Fosphenytoin SodiumFosphenytoin Sodium
64679-729FOSPHENYTOIN SODIUMfosphenytoin sodium
64679-730FOSPHENYTOIN SODIUMfosphenytoin sodium
65162-998Fosphenytoin SodiumFosphenytoin Sodium

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.